ArticleBreast cancer research and treatment2022

BluePrint breast cancer molecular subtyping recognizes single and dual subtype tumors with implications for therapeutic guidance.

Midas M Kuilman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.